Tag: Kadcyla

May 3, 2019 Off

FDA Approves Genentech’s Kadcyla for Adjuvant Treatment HER2-Positive Early Breast Cancer

Approval based on data showing Kadcyla cut the risk of diseaserecurring by half compared to Herceptin in the adjuvant setting forspecific patients with HER2-positive early breast cancer

November 17, 2015 Off

Roche breast cancer drug at centre of UK pricing row

By Dino Mustafić

A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the centre of a drug pricing row after Britain’s health cost agency declared that it is still too expensive.